ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • Search
  • My Favorites
    • View and print all favorites
    • Clear all favorites

Abstracts tagged "Janus Kinase inhibitors"

  • Abstract Number: 0195 • ACR Convergence 2021

    JAK Inhibitors in Refractory Adult and Childhood-Onset Still’s Disease

    Louise GILLARD1, Stéphane Mitrovic2, Jacques Pouchot3, Fleur Cohen1, Martin Michaud4, Heloise Reumaux5, Isabelle Kone-Paut6 and Bruno Fautrel7, 1Pitié Salpêtrière Hospital, Paris, France, 2Pitié Salpêtrière Hospital - Institut Mutaliste Montsouris, Paris, France, 3AP-HP, RUEIL-MALMAISON, France, 4Joseph Ducuing Hospital, Toulouse, France, 5Jeanne de Flandre Hospital, Lille, France, 6APHP, Bicetre hospital, Le Kremlin bictre, France, 7Pitié Salpêtrière Hospital, APHP, Sorbonne Université, Paris, France

    Background/Purpose: Excessive and inappropriate production of pro-inflammatory cytokines such as interleukin IL-1, IL-6 or IL-18, is a pathogenic cornerstone in adult and childhood onset Still’s…
Advanced Search

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology